Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Dopamine agent"'
Autor:
Jodi Cartoon, Jothi Ramalingam
Publikováno v:
Australasian Psychiatry. 27:456-461
Objectives: To explore the presence of dopamine dysregulation syndrome in non-Parkinson’s disease patients receiving dopamine replacement therapy. Methods: Electronic searches were conducted of Medline, Embase, PsycINFO and PreMedline to capture ar
Autor:
Akito Shikama, Kana Santo, Taiki Sato, Hiroaki Suzuki, Hitoshi Shimano, Yoko Sugano, Shigeru Yatoh, Miyoko Omoto-Inuzuka, Kazuhiro Takekoshi, Hisato Hara, Erika Matsumura-Matsuda, Hitoshi Iwasaki, Motohiro Sekiya, Motoko Kuba
Publikováno v:
Internal Medicine
We herein report a case of pheochromocytoma occurring in the course of Parkinson’s disease. The coexis-tence of these two disease is extremely rare, with only four cases hitherto reported across the public data- bases. It is also noteworthy that bi
Publikováno v:
The Nurse Practitioner. 45:11-12
Publikováno v:
European journal of medicinal chemistry. 181
The discovery and development of multitarget-directed ligands (MTDLs) is a promising strategy to find new therapeutic solutions for neurodegenerative diseases (NDs), in particular for Alzheimer's disease (AD). Currently approved drugs for the clinica
Publikováno v:
Clinical Medicine. 16:379-382
Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a common movement disorder characterised by an uncontrollable urge to move because of uncomfortable, sometimes painful sensations in the legs with a diurnal variation and a re
Publikováno v:
Der Nervenarzt. 87:418-425
Lendenwirbelsaulen (LWS)-Schmerzen sind ein haufiges Symptom bei Patienten mit fortgeschrittenem Morbus Parkinson. Wir untersuchten die Auswirkungen von Veranderungen der dopaminergen Medikation, verschiedenen Infiltrationstechniken sowie Analgetika
Autor:
Scott M. Rawls, James Mooney
Publikováno v:
Behavioural Pharmacology. 28:405-407
The efficacy of KCNQ2/3 channel agonists against drug reward has not been defined despite their ability to reduce locomotor-stimulant and dopamine-activating effects of psychostimulants. We tested the hypothesis that flupirtine (FLU) (2.5, 10, 20 mg/
Autor:
Thomas J. McLaughlin, Jennifer Neary, David Siwicki, Lyle Fried, Kenneth Blum, Mary Hauser, R D Badgaiyan, Downs Bw, Marjorie C. Gondré-Lewis, David Baron, Edward J Modestino, Bruce Steinberg, John Giordano
Publikováno v:
Journal of systems and integrative neuroscience
The well-researched pro-dopamine regulator KB220 and variants result in increased functional connectivity in both animal and human brains, and prolonged neuroplasticity (brain cell repair) having been observed in rodents. Moreover, in addition to inc
In the past decades, many efforts were undertaken to develop ligands for the adenosine receptors, with the purpose to individuate agonists and antagonists affinity and selectivity for each subtypes, namely A1, A2A, A2B, and A3. These intense studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caea11a137a342ba1faf6caffd861a23
http://hdl.handle.net/11392/2396576
http://hdl.handle.net/11392/2396576
Publikováno v:
Neuropsychiatric Disease and Treatment
Evgeniy A Gorbunov, Irina A Ertuzun, Evgeniya V Kachaeva, Sergey A Tarasov, Oleg I EpsteinOOO “NPF “MATERIA MEDICA HOLDING”, Moscow, Russian FederationAbstract: Experimentally and clinically, it was shown that released-active form of antibodies